Novan’s Nitric Oxide-Based Acne Gel Passes Safety Hurdle

Top-line results of US Phase 2b trial of Novan Therapeutics' SB204 in 200 subjects with acne are expected by the third quarter of this year. The Phase 3 pivotal clinical trials with SB204 should begin in the first quarter of 2016.